Table 1.
Characteristics and results of the elderly population with AF.
| Variable | FALL | TOTAL | p-value | ||||
| NO | YES | ||||||
| Female | 28 | 45.16% | 34 | 54.84% | 62 | 0.283 | *) |
| Age (years) | 77. 07 + 6. 58 | 78. 46 + 6. 29 | 77. 86 + 6. 42 | 0.276 | # | ||
| BMI (kg/m2) | 28 (19 - 55) | 26 (19 - 38) | 27 (19 - 55) | 0.444 | ## | ||
| Visual deficiency | 32 | 42.11% | 44 | 57.89% | 76 | 0.005 | *) |
| Hearing deficiency | 19 | 45.24% | 23 | 54.76% | 42 | 0.029 | ** |
| Physical activity | 10 | 45.45% | 12 | 54.55% | 22 | 0.705 | *) |
| Symptoms | 39 | 43.33% | 48 | 53.33% | 90 | 0.015 | *) |
| Palpitations | 25 | 41.67% | 35 | 58.33% | 60 | 0.044 | *) |
| Tiredness | 28 | 37.33% | 47 | 62.67% | 75 | 0.001 | *) |
| Paresthesias | 16 | 38.10% | 26 | 61.90% | 42 | 0.037 | *) |
| Cephalea | 4 | 26.67% | 11 | 73.33% | 15 | 0.041 | *) |
| Syncopes | 0 | 0.00% | 5 | 100.00% | 5 | 0.027 | *** |
| Muscle strength | |||||||
| Hand grip | 19 | 45.24% | 30 | 71.43% | 42 | 0.021 | *** |
| Quadríceps | 17 | 40.48% | 25 | 59.52% | 42 | 0.001 | ** |
| CHF FC I/II | 22 | 50.00% | 22 | 50.00% | 44 | 0.934 | *) |
| Dilated myocardiopathy | 26 | 39.39% | 40 | 60.61% | 66 | 0.085 | *) |
| Mitral failure | 11 | 55.00% | 9 | 45.00% | 20 | 0.586 | *) |
| Coronary failure | 5 | 29.41% | 12 | 70.59% | 17 | 0.077 | *) |
| CHF FC III | 2 | 15.38% | 11 | 84.62% | 13 | 0.009 | *) |
| Tricuspid failure | 7 | 53.85% | 6 | 46.15% | 13 | 0.739 | *) |
| Aortic failure | 6 | 85.71% | 1 | 14.29% | 7 | 0.112 | *** |
| Previous AMI | 1 | 16.67% | 5 | 83.33% | 6 | 0.205 | *** |
| COMORBIDITIES | |||||||
| Obesity | 17 | 51.52% | 16 | 48.48% | 33 | 0.731 | *) |
| Diabetes mellitus | 5 | 25.00% | 15 | 75.00% | 20 | 0.015 | *) |
| Neuropathies | 6 | 30.00% | 14 | 70.00% | 20 | 0.052 | *) |
| COPD | 6 | 33.33% | 12 | 66.67% | 18 | 0.131 | *) |
| Depression | 8 | 47.06% | 9 | 52.94% | 17 | 0.824 | *) |
| Thyropathies | 8 | 47.05% | 9 | 52.94% | 17 | 0.487 | ** |
| Peripheral vascular disease | 9 | 60.00% | 6 | 40.00% | 15 | 0.381 | *) |
| Rheumatological diseases | 3 | 33.33% | 6 | 66.67% | 9 | 0.488 | *** |
| Chronic renal failure | 3 | 37.50% | 5 | 62.50% | 8 | 0.716 | *** |
| Gastric disorders | 1 | 14.29% | 6 | 85.71% | 7 | 0.113 | *** |
| Prostatism | 5 | 71.43% | 2 | 28.57% | 7 | 0.265 | *** |
| Pulmonary hypertension | 2 | 28.57% | 5 | 71.43% | 7 | 0.437 | *** |
| Neoplasia | 2 | 33.33% | 4 | 66.67% | 6 | 0.678 | *** |
| Epilepsy | 2 | 66.67% | 1 | 33.33% | 3 | 0.598 | *** |
| Scores | |||||||
| HAQ | 0.72 0-2.25) | 1.20 (0-2.88) | 0.97 (0-2.88) | 0,002*) | ## | ||
| MMSE | 25 (9-30) | 23.98(7-30) | 24.47(7-30) | 0,1761 | ## | ||
| Timed Up & Go | 11 (6 - 30) | 13 (8 - 56) | 12 (6 - 56) | 0.063 | ## | ||
| Gait POMA | 11 (5 - 13) | 11 (2- 12) | 11 (2 - 13) | 0.148 | ## | ||
| Balance POMA | 16 (8 - 16) | 15 (1 - 16) | 16 (1 - 16) | 0.018 | ## | ||
| Berg Balance Scale | 51 (20 - 56) | 51 (15 - 56) | 51 (15 - 56) | 0.224 | ## | ||
*
Chi-square test **Likelihood ratio test *** Fisher's exact test.
# Student's t-test ## Wilcoxon's rank sum test.